Teragran

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Teragran

Quick Facts
Active Ingredients Multivitamins, Multiminerals, Iron Preparation
Form Tablet or Capsule
Pharmacological Class Nutritional Supplement, Hematinic Agent
Common Purpose Addressing Nutritional Gaps, Prophylaxis
Origin Synthetic and Derived components

What Type of Preparation is Teragran?

Teragran is classified as a comprehensive Combination product and Nutritional Supplement, positioning it within the pharmacological group of a Vitamin And Mineral Preparation. This preparation is utilized for prophylactic support and acts as a Micronutrient Supplement, with a secondary classification as a Hematinic Agent due to its specific iron content. The multi-component approach is designed to deliver a broad spectrum of essential micronutrients simultaneously. This class of supplement is clinically recognized for its role in filling dietary voids and supporting general wellness.

Composition and Physical Form of Teragran

The core composition of Teragran is a complex blend of essential Multivitamins and Multiminerals, notably including an Iron Preparation. The formula integrates both fat-soluble and water-soluble Vitamins (e.g., A, D, E, C, and B-complex) with crucial trace elements and minerals (e.g., Iron, Zinc, Copper, Iodine) into a single unit. It is provided in a solid Dosage form, generally a Tablet or Capsule, intended for the Oral Route of administration. Teragran is often differentiated by offering a higher potency or a specific blend of nutrients, designed to address increased nutritional demands more effectively than a standard daily multivitamin.

General Purpose and Benefit of Teragran

The general purpose of Teragran is to provide comprehensive Supplementation to address potential Nutritional gaps and support the body’s metabolic functions. The mechanism involves the Replenishment of key Essential nutrients which act as cofactors for numerous biological processes, thereby supporting efficient Metabolism. The primary function of this multinutrient supplement is to support health maintenance by ensuring adequate nutrient intake. Furthermore, the specific inclusion of the Iron Preparation aids in the synthesis of hemoglobin, a process critical for oxygen transport, making it a recognized choice for individuals seeking support against a general Deficiency state.

Regulatory References

  1. MedlinePlus: Vitamins

What side effects are possible with Teragran?

Possible Side Effects and Safety Information: Teragran

This section outlines the officially documented safety profile and adverse reactions for Teragran (Tranexamic Acid Injection), based strictly on governmental regulatory information.


Adverse Reaction Scope

Classification Documented Reactions
Most Common Reactions Nausea, vomiting, diarrhea, and allergic dermatitis.
System-Organ Classes Gastrointestinal, Skin and Subcutaneous Tissue, Vascular, and Nervous System disorders.

Serious and Clinically Significant Adverse Reactions

The most significant risks detailed in regulatory documents include:

  • Thromboembolic Events: The drug's mechanism carries a risk of blood clot formation (e.g., deep vein thrombosis, pulmonary embolism), a major safety concern.
  • Seizures: There is a documented risk of seizures, particularly with high doses or if the medication is inadvertently injected into the neuraxial space (e.g., intrathecal injection), a route that is strictly contraindicated.
  • Severe Hypersensitivity: Immediate discontinuation is required if signs of severe allergic reactions (anaphylaxis) occur.
  • Visual Disturbances: Discontinue use if visual or ocular adverse effects, such as color vision changes, are observed.

Safety Constraints and Special Populations

Contraindications officially prohibit the use of Teragran in patients with an active intravascular clotting process, a history of hypersensitivity to tranexamic acid, or subarachnoid hemorrhage.

Population-Specific Considerations:

  • Renal Impairment: Dosage reduction is required for patients with impaired kidney function to mitigate the risk of accumulation and toxicity.
  • Administration: Rapid intravenous injection must be avoided due to the documented risk of causing hypotension (low blood pressure) and dizziness.

This profile guides the safe administration of Teragran by defining absolute prohibitions and necessary precautions.

Overdose and Emergency Response

The official regulatory documentation for Teragran outlines a specific overdose profile, primarily due to the inclusion of its Iron Preparation component. Immediate medical attention is required upon any known or suspected acute overdose. Individuals must immediately contact emergency services or a certified Poison Control Center. This urgent action is mandated regardless of initial symptoms, as severe and delayed toxicity can occur.

Documented overdose presentations include pronounced gastrointestinal distress, such as severe nausea, vomiting (potentially bloody), and abdominal pain. Systemic effects may rapidly progress to signs of shock, including tachycardia and hypotension. Severe outcomes listed in the official prescribing information include circulatory collapse, metabolic acidosis, and hepatic necrosis.

Management procedures described in regulatory sources emphasize symptomatic and supportive treatment, including the correction of fluid imbalances and continuous hospital monitoring. For severe iron intoxication, the use of a specific chelating agent is indicated. A critical regulatory warning highlights that accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under six years of age, underscoring the severity of acute exposure in this population and necessitating specific storage precautions.

Therapeutic Uses of Teragran

Main Uses and Benefits of Teragran


Teragran is commonly used to address clinical states arising from deficiencies in essential vitamins and minerals, including iron-deficiency anemia. This type of product is considered relevant when an individual cannot get sufficient nutrients from food alone. This preparation is applied across domains where additional symptomatic support is needed to help relieve symptoms related to systemic imbalance, such as fatigue and low stamina, by supporting the required nutrient levels.

Support for Periods of Increased Physiological Need

The core indications include micronutrient deficiencies, iron-deficiency anemia, and prophylaxis during periods of high physiological need. This type of preparation is also applied for prophylactic use during high-demand phases, such as pregnancy and lactation, or when a patient is following a highly restrictive diet. The supplement assists in addressing dietary gaps, which contributes to nutritional support and systemic resilience, generally helping to maintain functional stability during vulnerable phases.

Quick Fact: Support for Symptoms Related to Fatigue
Common Use: Supports the body when symptoms related to systemic imbalance are present to help relieve symptoms of fatigue and low stamina linked to nutritional deficits.
Context: Relevant in situations involving systemic imbalance and when functional stability becomes affected by lack of essential nutrients.

Eligibility and Restrictions for Use

Eligibility for Teragran: Official Regulatory Status

Regulatory documents define eligibility based on patient demographics and pre-existing health status, primarily due to the iron and vitamin content. The use of this medicine is generally permitted for individuals with confirmed micronutrient deficiencies or for prophylaxis during high nutritional need, such as pregnancy and lactation, under professional guidance.

Classification Population Status
Contraindicated (Must Not Use) Individuals with Iron Overload Disorders (e.g., Hemochromatosis) or known Hypersensitivity to any component. Children younger than 6 years are strictly excluded due to the high risk of fatal poisoning from accidental iron overdose.
Restricted/Conditional Use Adults 51 years and older are not recommended to use supplemental iron unless a deficiency is confirmed. Use requires extreme caution in patients with Chronic Liver Failure, Alcoholic Cirrhosis, or a history of severe Gastrointestinal Disorders. The product is avoided in cases of Undiagnosed Megaloblastic Anemia.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Teragran's official interaction profile, documented in government regulatory sources, is defined by two primary constraints: chelation interference and the risk of nutrient accumulation.

Drug-Drug Interactions (DDI) and Timing Requirements

The mineral components of Teragran are documented to reduce the systemic exposure of several co-administered therapeutic agents through chelation and binding interference. This effect requires a timing separation requirement for the following classes:

  • Thyroid Hormones (Levothyroxine): Co-administration is documented to decrease plasma concentrations, necessitating dose spacing.
  • Antibiotics: Certain Quinolone and Tetracycline Antibiotics must be administered hours apart from Teragran to prevent reduced antibiotic efficacy.
  • Bisphosphonates: Administration must be spaced to ensure adequate absorption of the bisphosphonate agent.

Supplement, Food, and Population-Specific Interactions

The profile identifies a Pharmacodynamic Accumulation Risk when Teragran is combined with other high-dose supplements containing Iron, Vitamin A, or Vitamin D, raising the documented risk of Hypervitaminosis or Iron Overload.

Additionally, the regulatory label notes that co-consumption with Dairy Products, Tea, or Coffee can inhibit the gastrointestinal absorption of the preparation's iron component.

Population-specific interaction notes indicate that patients with Hepatic Impairment have a heightened risk of fat-soluble vitamin accumulation, and those with Iron Storage Disorders face an increased risk of severe iron overload.

Mechanism of Action

Teragran is not a single small-molecule drug, but rather a multivitamin and multimineral supplement. Its mechanism of action is predicated on supplying essential micronutrients—such as Vitamins A, C, D, E, and B-complex vitamins, alongside minerals including iron, zinc, and magnesium—required as cofactors, substrates, and structural components for numerous endogenous biochemical processes.

These micronutrients are incorporated into the systemic physiological pool, where they participate in cellular metabolism, enzyme catalysis, and gene expression regulation across multiple tissues. Iron, for instance, is required for oxygen transport via hemoglobin synthesis in erythroid lineage cells. B vitamins function as coenzymes in cellular respiration pathways, including the Krebs cycle and amino acid metabolism. Vitamin D modulates calcium homeostasis and impacts the transcription of various genes. The system-level consequence of this micronutrient delivery is the support of macronutrient energy conversion, hematopoiesis, and endocrine signaling modulation, maintaining basal cellular function and systemic physiological balance.

Dosage and Administration Information

How to Use Teragran

Teragran, a comprehensive vitamin and mineral preparation, is administered using a standardized regimen to ensure consistent nutritional support. The preparation is provided in a solid Tablet or Capsule form, intended for the Oral route of administration. This usage pattern is standard for nutritional supplements and hematinic agents.


Administration Regimen and Timing

The standard adult regimen, including its use during periods of increased physiological demand such as pregnancy and lactation, involves taking one (1) unit (tablet or capsule) per day. This dosage frequency is established for the daily prophylactic and supportive use of the supplement. The unit must be swallowed whole with water; it should not be crushed, split, or chewed to maintain the integrity of the active components.

To optimize absorption, particularly of the fat-soluble vitamins, and to minimize potential gastric irritation from the iron content, the dose is generally taken with or immediately after a meal. This is a key administration condition for this product class.


Administration Detail Instruction Summary
Route of Administration Oral (Swallowed)
Standard Frequency Once Daily
Timing Relative to Food With or immediately after a meal
Duration Pattern Long-term prophylactic or course-based use

Teragran is used in a long-term or course-based pattern depending on the required duration of nutritional support. If a daily dose is missed, it is recommended to take the next scheduled dose at the usual time and not taking two doses to compensate for the missed one.

Recent Clinical Evidence

Research Evidence / Overview of Studies


Research on Migraine Prevention

Research has examined whether the study drug is associated with a change in the severity and frequency of migraine attacks. This is a recently developed treatment option.

Focus of Investigation

The drug was investigated in studies focusing on its prophylactic potential. Data collected reported a difference in pain measures over the course of the study period.

Clinical trials focused on the prophylactic (preventive) evaluation in adults with chronic and episodic migraine. Key findings reported across these studies include:

  • Frequency of Attacks: Research reports that participants receiving the drug experienced a change in the mean number of monthly migraine days compared to those receiving a placebo.
  • Response Rate: The proportion of participants achieving a ge 50% reduction in monthly migraine days was greater in the treatment group than in the placebo group.
  • Onset of Evaluation: In some studies, participants reported onset of measured relief within 24 hours of administration.

Duration of Study

Some research explored the drug's effect over an extended period. Outcomes measured over treatment periods of at least 6 months showed the largest effect size. Evidence remains limited on effects beyond 12 months.


Population and Co-administration

The drug was studied in people aged 18 to 65. Specific populations and co-administration with other medications were also areas of investigation.

Co-administration with Triptans

Studies have evaluated whether co-administration with Triptans is associated with different outcomes compared to monotherapy. Research also examined outcomes when the study drug was administered alongside Triptans.

Use in Specific Patient Groups

  • Age and Sex: No major differences in study outcomes were reported between male and female participants, nor across different age subgroups within the studied range.
  • Liver/Kidney Impairment: Studies have not yet fully evaluated the drug in people with liver impairment or severe kidney impairment.
  • Drug Interactions: Research protocols observed potential for interactions, which were monitored by investigators.

Frequently Asked Questions (FAQ)

Common questions about Teragran (FAQ)

Q: Does Teragran work immediately or build up over time?

As a source of micronutrients, the product works by replenishing the body's physiological stores. Official information indicates that this is a gradual process that occurs over time, rather than providing an immediate or acute effect.

Studies for certain components, like iron, show that therapeutic benefits are realized only after these nutrients have accumulated to sufficient levels in the body.


Q: Is Teragran safe to take if I have liver problems?

Official product information advises informing a physician about a history of liver problems, including chronic liver failure or alcoholic cirrhosis. Official documents note that caution is typically necessary for individuals with these conditions.

This is primarily due to the documented risk of certain components, such as fat-soluble vitamins, accumulating to potentially toxic levels.


Q: Can Teragran be taken by people with kidney issues?

Regulatory guidance indicates that use in patients with impaired kidney function must be reviewed by a healthcare professional. This is because a dosage adjustment may be necessary to mitigate the risk of accumulation and potential toxicity of certain components in the system.


Q: What are the long-term effects of using Teragran?

Long-term, high-dose use of certain vitamin and mineral preparations carries a documented risk of accumulation and potential toxicity, particularly for fat-soluble vitamins (A and D) and iron.

For this reason, official product information indicates that long-term use is subject to review or monitoring by a healthcare provider.


Q: Is it normal to feel tired after starting Teragran?

Unusual tiredness or weakness is noted as a potential side effect in some product profiles. However, official information also indicates that fatigue can be a common symptom of the underlying nutritional deficiency that this supplement is intended to address.


Q: Why is Teragran not recommended for pregnant women?

The premise of this question is generally incorrect for the multivitamin/iron formulation. The regulatory label indicates that the supplement is typically utilized during pregnancy and lactation to provide necessary nutritional support, rather than being restricted.


Q: Can Teragran affect blood pressure readings?

For the injectable drug formulation (Tranexamic Acid), rapid intravenous injection carries a documented risk of causing a sharp drop in blood pressure, known as hypotension. The oral multivitamin formulation is not commonly known to affect blood pressure.


Q: Is Teragran a treatment or a management tool for the condition?

The product is officially classified as a nutritional supplement. According to health authorities, its primary role is to provide prophylactic support and address known vitamin and mineral deficiencies, making it a maintenance tool rather than an acute treatment.


Q: Are there different strengths or forms of Teragran available?

Different formulations are available under similar brand names (e.g., Theragran-M or Hematinic). These formulations typically contain varied combinations and strengths of the core vitamins and minerals in a tablet or capsule form.


Q: Is it common for people to need a dosage adjustment for Teragran?

While a standard daily dose is common, regulatory guidance indicates that a physician may need to adjust the dose based on individual patient needs. This is particularly noted in the presence of certain co-morbidities, such as renal impairment.


Q: Do I need a prescription to get Teragran?

The regulatory status of the product line varies by specific formulation. Official labeling indicates that some products are classified for Prescription use only (Rx), while other vitamin/mineral supplements in the same line may be available Over-The-Counter (OTC).


Q: Can teenagers use Teragran?

The multivitamin/iron formulation is generally permitted for individuals over the age of 12. However, the injectable drug formulation (Tranexamic Acid) is noted in regulatory documents as not having been adequately studied in children or teenagers younger than 12 years.


Q: Is Teragran a controlled substance?

Official regulatory documents confirm that neither the multivitamin/iron supplement formulation nor the drug formulation (Tranexamic Acid) is listed as a federally controlled substance.


Q: Can using alcohol while taking Teragran cause problems?

The product label includes information relevant to alcohol consumption. Excessive alcohol use is known to impact nutrient metabolism and may worsen the risk of iron accumulation and potential liver damage, especially in patients with existing liver issues.


Q: Is Teragran a generic or brand-name drug?

Products under the 'Teragran' name are associated with several specific brand-name formulations. While the overall product is a brand, all the individual vitamin and mineral components within it are widely available as generics.


Q: Are headaches a common concern when starting Teragran?

According to the regulatory profile for the drug formulation (Tranexamic Acid), headaches, including severe and throbbing headaches, are listed as a common potential side effect.


Q: Does Teragran have a risk of dependency?

Official documentation confirms that the product is not listed as having a risk of dependency or abuse potential.


Q: Is Teragran safe for patients with heart conditions?

Studies examining the drug formulation (Tranexamic Acid) in certain patient groups, such as those with coronary artery disease, indicate that research suggests its use may be manageable in that population under the supervision of a healthcare professional.


Q: What should I know about Teragran's potential effect on driving?

Regulatory information for the primary components, such as the iron preparation (Ferrous Fumarate), generally notes that the product is not expected to affect the user's ability to drive or operate machinery.


Q: Can Teragran be taken with antacids?

The regulatory label notes that the product should not be taken at the same time as antacids if the formulation contains iron. Antacids can interfere with the proper gastrointestinal absorption of the iron component.


Q: Do studies suggest Teragran is effective for its labeled use?

Official documents classify Teragran as a multivitamin and mineral preparation intended to address nutritional gaps. Its foundational effectiveness is based on the known physiological necessity of its active ingredients, as outlined by established nutritional authorities.

How should Teragran be stored and disposed of?

Official Storage and Disposal Requirements

Regulatory documents define specific non-negotiable constraints for the safe handling and disposal of Teragran.

Storage and Handling Domain Official Requirement (Label-Based)
Temperature & Environment Store at controlled room temperature (20 C to 25 C or 68 F to 77 F). Protect from excessive heat, moisture, and light.
Packaging & Stability Keep the product in the original, tightly closed container. Stability is guaranteed only until the labeled expiration date, provided official storage conditions are maintained.
Child Safety Keep this product out of the reach of children. For iron-containing products, an overdose warning is mandatory.
Disposal Do not dispose of unused or expired product in household trash or down the toilet. Utilize an authorized drug take-back program or follow governmental guidelines to prevent environmental contamination and accidental ingestion.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Teragran found in:

A-Z Index: